Literature DB >> 26159600

Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up.

Aran Tajika1, Yusuke Ogawa2, Nozomi Takeshima2, Yu Hayasaka2, Toshi A Furukawa2.   

Abstract

BACKGROUND: Contradictions and initial overestimates are not unusual among highly cited studies. However, this issue has not been researched in psychiatry. Aims: To assess how highly cited studies in psychiatry are replicated by subsequent studies.
METHOD: We selected highly cited studies claiming effective psychiatric treatments in the years 2000 through 2002. For each of these studies we searched for subsequent studies with a better-controlled design, or with a similar design but a larger sample.
RESULTS: Among 83 articles recommending effective interventions, 40 had not been subject to any attempt at replication, 16 were contradicted, 11 were found to have substantially smaller effects and only 16 were replicated. The standardised mean differences of the initial studies were overestimated by 132%. Studies with a total sample size of 100 or more tended to produce replicable results.
CONCLUSIONS: Caution is needed when a study with a small sample size reports a large effect. © The Royal College of Psychiatrists 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26159600     DOI: 10.1192/bjp.bp.113.143701

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  16 in total

1.  Replication and contradiction of highly cited research papers: a lesson for the Secretary of State for Health?

Authors:  Roxanne Keynejad; Clare Holt; Tony Rao
Journal:  BJPsych Bull       Date:  2015-12

2.  Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.

Authors:  Mark Weiser; Linda Levi; Daisy Zamora; Anat Biegon; John Paul SanGiovanni; Michael Davidson; Shimon Burshtein; Ilan Gonen; Paull Radu; Kristina Slobozean Pavalache; Igor Nastas; Rina Hemi; Timothy Ryan; John M Davis
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

3.  Tracing scientific reasoning in psychiatry: Reporting of statistical inference in abstracts of top journals 1975-2015.

Authors:  Christopher Baethge; Markus Deckert; Andreas Stang
Journal:  Int J Methods Psychiatr Res       Date:  2018-08-02       Impact factor: 4.035

4.  Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.

Authors:  Gustavo C Medeiros; Todd D Gould; William L Prueitt; Julie Nanavati; Michael F Grunebaum; Nuri B Farber; Balwinder Singh; Sudhakar Selvaraj; Rodrigo Machado-Vieira; Eric D Achtyes; Sagar V Parikh; Mark A Frye; Carlos A Zarate; Fernando S Goes
Journal:  Mol Psychiatry       Date:  2022-06-27       Impact factor: 15.992

Review 5.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

6.  GRM8 genotype is associated with externalizing disorders and greater inter-trial variability in brain activation during a response inhibition task.

Authors:  Lance O Bauer; Jonathan M Covault
Journal:  Clin Neurophysiol       Date:  2020-04-02       Impact factor: 3.708

Review 7.  The influence of ketamine on drug discovery in depression.

Authors:  Christoph Kraus; Daniel Wasserman; Ioline D Henter; Elia Acevedo-Diaz; Bashkim Kadriu; Carlos A Zarate
Journal:  Drug Discov Today       Date:  2019-08-02       Impact factor: 7.851

8.  Replication Validity of Initial Association Studies: A Comparison between Psychiatry, Neurology and Four Somatic Diseases.

Authors:  Estelle Dumas-Mallet; Katherine Button; Thomas Boraud; Marcus Munafo; François Gonon
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

9.  Poor replication validity of biomedical association studies reported by newspapers.

Authors:  Estelle Dumas-Mallet; Andy Smith; Thomas Boraud; François Gonon
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

10.  Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study.

Authors:  S R T Veerman; P F J Schulte; J D Smith; L de Haan
Journal:  Psychol Med       Date:  2016-04-06       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.